Trial Profile
A Clinical Research on the Safety/Efficacy of Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Spinocerebellar Ataxia
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Apr 2023
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary) ; Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary)
- Indications Spinocerebellar ataxias
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 11 Apr 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 11 Apr 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.
- 11 Apr 2023 Planned initiation date changed from 1 Dec 2022 to 1 Dec 2023.